Lava Therapeutics Nv's Customers Performance

Name: Lava Therapeutics Nv Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

LVTX

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


LVTX's Source of Revenues		• List of LVTX Customers

for the same period Lava Therapeutics Nv

• List of LVTX Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Lava Therapeutics Nv's Comment on Sales, Marketing and Customers

News about Lava Therapeutics Nv Contracts

Evolving Cancer Treatment: Pfizer Achieves Clinical Milestone in Breakthrough Drug PF-08046052

Clinical Milestone Achieved by Pfizer in Phase 1 Study of PF-08046052 - A Potential Breakthrough in Cancer TreatmentIn the ever-evolving field of medical research, groundbreaking advancements are essential to combatting diseases and improving patient outcomes. One such milestone has recently been achieved by global pharmaceutical giant Pfizer in the clinical development of PF-08046052 (formerly known as SGN-EGFRd2/LAVA-1223). This milestone was triggered by significant progress in a Phase 1 study, which was initiated in the fourth quarter of 2023. The potential implications of this achievement are immense, as it presents a beacon of hope for cancer patients worldwide.Phase 1 Study and Clinical Progress:The P...

A Revolutionary Collaboration: LAVA Therapeutics and Merck Join Forces to Revolutionize mCRPC Treatment

LAVA Therapeutics and Merck Join Forces to Revolutionize mCRPC Treatment: A Promising Collaboration to Explore Combination TherapyIn a major stride towards advancing treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC), LAVA Therapeutics recently announced a groundbreaking collaboration with Merck and Co., Inc., based in Rahway, New Jersey. This strategic partnership aims to assess the potential of combining LAVA s innovative therapy, LAVA-1207, with Merck s renowned immunotherapy drug, KEYTRUDA.LAVA Therapeutics, a clinical-stage biotechnology company focused on developing and commercializing transformative immunotherapies, is at the forefront of the race to improve ou...

LVTX's Stock Performance relative to it's Customers

LVTX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Lava Therapeutics Nv	46.80	0.00	0.00	-
SUBTOTAL	0.00	0.00	0.00	-

Sources: Lava Therapeutics Nv’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Lava Therapeutics Nv’s corporate clients.
For your research, we’ve provided 9 tables on Lava Therapeutics Nv corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.